Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR Medical Informatics

Date Submitted: Apr 13, 2026
Open Peer Review Period: Apr 28, 2026 - Jun 23, 2026
(currently open for review)

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Attention-based Neuro-Symbolic Regularization for Multi-Label Classification of Diabetic Complications: Algorithm Development and Validation Study

  • Zhengxi Liang; 
  • Weijie Qin; 
  • Yingmin Deng; 
  • Runrong Jiang; 
  • Linxiang Zhu; 
  • Weikeng Liang; 
  • Chuyun Chen; 
  • Wen Shi

ABSTRACT

Background:

Early and accurate identification of diabetic complications is crucial for reducing the associated high rates of morbidity and mortality. In particular, microvascular and macrovascular complications represent the most prevalent and critical conditions that determine patient prognosis. Although machine learning methods show promise, several limitations hinder their successful translation into clinical practice. Many methods rely on hard to acquire clinical data and overlook the pathological relationships among complications. Additionally, the propensity of purely data driven models to capture spurious correlations hinders application in clinical practice.

Objective:

This study aims to address these limitations. The goal is to develop a low-cost, clinically applicable framework the screening of major diabetic complications including microvascular and macrovascular conditions. In this way, the research seeks to improve clinical plausibility and facilitate the practical application of classification models in resource limited settings.

Methods:

This study proposes a novel diagnostic framework: the Attention-based Neuro-Symbolic Regularization Framework (ANSR). First, the framework constructs an effective feature set by integrating accessible immune-inflammatory biomarkers. Subsequently, an Attention-based Neural Perception Module (ABNP) is employed to extract non-linear risk features from these data. To bridge the gap between data patterns and clinical logic, a Bi-level Symbolic Logic Regularization Mechanism (BSLR) is introduced. This mechanism enforces constraints through two components: a pairwise co-occurrence regularizer that encodes explicit correlation patterns, and a high-order global pattern regularizer that mines global association rules.

Results:

Experimental results demonstrate that ANSR outperforms all mainstream baseline models in key metrics such as accuracy and Precision-Recall curve. Moreover, the McNemar test confirms that ANSR achieves a statistically significant advantage over all baseline models across all five complications .

Conclusions:

These findings suggest that the proposed ANSR framework has substantial potential for early and accurate screening of major diabetic complications and for supporting reliable clinical decision-making.


 Citation

Please cite as:

Liang Z, Qin W, Deng Y, Jiang R, Zhu L, Liang W, Chen C, Shi W

Attention-based Neuro-Symbolic Regularization for Multi-Label Classification of Diabetic Complications: Algorithm Development and Validation Study

JMIR Preprints. 13/04/2026:98063

DOI: 10.2196/preprints.98063

URL: https://preprints.jmir.org/preprint/98063

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.